Close
Back to ITOS Stock Lookup
Pages: 1 2 3 »» Last Page

(ITOS) – Company Press Releases

Apr 7, 2024 04:30 PM iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024
Mar 6, 2024 07:01 AM iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors
Mar 6, 2024 07:00 AM iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
Mar 5, 2024 04:30 PM iTeos to Highlight Preclinical Data on First-In-Class EOS-984 Targeting ENT1 at the American Association for Cancer Research Annual Meeting 2024
Mar 1, 2024 07:00 AM iTeos to Participate in Upcoming Investor Conferences
Jan 8, 2024 07:00 AM iTeos Announces 2024 Strategic Priorities and Anticipated Milestones
Jan 3, 2024 07:00 AM iTeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Nov 21, 2023 07:00 AM iTeos to Present at the Piper Sandler 35th Annual Healthcare Conference
Nov 7, 2023 07:00 AM iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates
Oct 11, 2023 05:55 PM NCR Atleos Set to Join S&P SmallCap 600
Sep 6, 2023 07:00 AM iTeos to Participate in Upcoming Investor Conferences
Aug 8, 2023 07:00 AM iTeos Reports Second Quarter 2023 Financial Results and Provides Business Updates
May 10, 2023 07:01 AM iTeos Reports First Quarter 2023 Financial Results and Provides Business Updates
Mar 15, 2023 07:00 AM iTeos Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
Mar 15, 2023 07:00 AM iTeos Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
Feb 28, 2023 07:00 AM iTeos to Present at Cowen 43rd Annual Health Care Conference
Feb 28, 2023 07:00 AM iTeos to Present at Cowen 43rd Annual Health Care Conference
Feb 7, 2023 07:00 AM iTeos to Present at SVB Securities Global Biopharma Conference
Feb 7, 2023 07:00 AM iTeos to Present at SVB Securities Global Biopharma Conference
Jan 9, 2023 07:00 AM iTeos Provides Business Updates and Clinical Development Plans for 2023
Jan 9, 2023 07:00 AM iTeos Provides Business Updates and Clinical Development Plans for 2023
Jan 3, 2023 07:00 AM iTeos to Present at the 41st Annual J.P. Morgan Healthcare Conference
Jan 3, 2023 07:00 AM iTeos to Present at the 41st Annual J.P. Morgan Healthcare Conference
Nov 22, 2022 07:00 AM iTeos to Present at the Piper Sandler 34th Annual Healthcare Conference
Nov 22, 2022 07:00 AM iTeos to Present at the Piper Sandler 34th Annual Healthcare Conference
Nov 10, 2022 04:01 PM iTeos Reports Third Quarter 2022 Financial Results and Provides Business Updates
Nov 10, 2022 04:01 PM iTeos Reports Third Quarter 2022 Financial Results and Provides Business Updates
Aug 10, 2022 04:01 PM iTeos Reports Second Quarter 2022 Financial Results and Provides Business Update
Aug 10, 2022 04:01 PM iTeos Reports Second Quarter 2022 Financial Results and Provides Business Update
Aug 2, 2022 07:00 AM iTeos to Present at the 2022 Wedbush PacGrow Healthcare Conference
Aug 2, 2022 07:00 AM iTeos to Present at the 2022 Wedbush PacGrow Healthcare Conference
Jun 13, 2022 04:39 AM Domain Therapeutics Appoints Dr Xavier Leroy as Chief Scientific Officer
May 12, 2022 04:01 PM iTeos Reports First Quarter 2022 Financial Results and Provides Business Update
May 12, 2022 04:01 PM iTeos Reports First Quarter 2022 Financial Results and Provides Business Update
Apr 12, 2022 02:00 AM Innoskel Appoints Dr Michel Detheux as Chairman
Apr 8, 2022 01:00 PM iTeos Presents New Data for Anti-TIGIT Antibody, EOS-448/GSK4428859A, at the AACR Annual Meeting 2022
Apr 8, 2022 01:00 PM iTeos Presents New Data for Anti-TIGIT Antibody, EOS-448/GSK4428859A, at the AACR Annual Meeting 2022
Mar 23, 2022 04:01 PM iTeos Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Mar 23, 2022 04:01 PM iTeos Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Mar 1, 2022 07:00 AM iTeos to Present at the Cowen 42nd Annual Health Care Conference
Mar 1, 2022 07:00 AM iTeos to Present at the Cowen 42nd Annual Health Care Conference
Feb 10, 2022 07:00 AM iTeos to Participate in Upcoming Investor Conferences in February
Feb 10, 2022 07:00 AM iTeos to Participate in Upcoming Investor Conferences in February
Jan 10, 2022 07:00 AM iTeos Provides Clinical Development Plans and Promotes Yvonne McGrath, Ph.D. to Chief Scientific Officer
Jan 10, 2022 07:00 AM iTeos Provides Clinical Development Plans and Promotes Yvonne McGrath, Ph.D. to Chief Scientific Officer
Jan 3, 2022 04:01 PM iTeos to Present at the 40th Annual J.P. Morgan Healthcare Conference
Jan 3, 2022 04:01 PM iTeos to Present at the 40th Annual J.P. Morgan Healthcare Conference
Dec 31, 2021 05:44 PM iTeos Therapeutics Set to Join S&P SmallCap 600
Dec 9, 2021 04:01 PM iTeos Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology Annual Meeting and TIGIT Therapies Digital Summit 2021
Dec 9, 2021 04:01 PM iTeos Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology Annual Meeting and TIGIT Therapies Digital Summit 2021
Pages: 1 2 3 »» Last Page

Back to ITOS Stock Lookup